The United States has launched a ‌trade investigation into a German plan to lower its spending on pharmaceutical products, U.S. Trade Representative ⁠Jamieson Greer said on Thursday.
The United States claims that there is evidence that “Germany implements unfair pricing policies and practices with regard to innovative pharmaceutical products,” according to the Office of the Trade Representative.
It added that there is also evidence “that reduced revenue associated with these acts, policies, and practices contributes to, among other things, reduced investment for R&D that supports the development of innovative pharmaceuticals.”
“I am particularly concerned with news that Germany is fast-tracking legislation that would further reduce its spending on innovative pharmaceuticals,” Greer said in a June 18 statement….